Home » Authors » Jim Stommen

Articles by Jim Stommen

Still optimistic: In a tough economy, VCs remain positive in their views on the med-tech sector

July 1, 2008

'Devastating' wounds: Common practice for war-zone surgeons

July 1, 2008

Physician/company ties draw close look by audience, media

June 1, 2008

Science, innovation abound; raising funds is the challenge

May 22, 2008

A look to 2020 offers both problems and opportunities

May 21, 2008

In difficult times, having 'calm urgency' is important

May 20, 2008

FDA official shares views on agency — but learns, too

May 19, 2008

Science, innovation abound; raising funds is the challenge

May 16, 2008

In tough economy, VCs still are optimistic about sector

May 15, 2008

Optimism, pessimism share podium in sector assessment

May 14, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 26, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 26, 2024.
J&J’s Ottava robotic system approved for US pivotal trial
BioWorld MedTech
Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.